Authors:
Riedel, C
Dohan, O
De la Vieja, A
Ginter, CS
Carrasco, N
Citation: C. Riedel et al., Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer, TRENDS BIOC, 26(8), 2001, pp. 490-496
Authors:
Zuckier, LS
Dadachova, E
Dohan, O
Carrasco, N
Citation: Ls. Zuckier et al., The endogenous mammary gland Na+/I- symporter may mediate effective radioiodide therapy in breast cancer, J NUCL MED, 42(6), 2001, pp. 987-987
Authors:
Dohan, O
Baloch, Z
Banrevi, Z
Livolsi, V
Carrasco, N
Citation: O. Dohan et al., Predominant intracellular overexpression of the Na+/I- symporter (NIS) in a large sampling of thyroid cancer cases, J CLIN END, 86(6), 2001, pp. 2697-2700
Authors:
Tazebay, UH
Wapnir, IL
Levy, O
Dohan, O
Zuckier, LS
Zhao, QH
Deng, HF
Amenta, PS
Fineberg, S
Pestell, RG
Carrasco, N
Citation: Uh. Tazebay et al., The mammary gland iodide transporter is expressed during lactation and in breast cancer, NAT MED, 6(8), 2000, pp. 871-878
Authors:
Takats, IK
Peter, F
Rimanoczi, E
Dohan, O
Foldes, J
Vadasz, J
Feldkamp, J
Szilagyi, G
Goth, M
Kovacs, L
Radacsi, A
Szabolcs, I
Citation: Ik. Takats et al., The blood spot thyrotropin method is not adequate to screen for hypothyroidism in the elderly living in abundant-iodine intake areas: Comparison to sensitive thyrotropin measurements, THYROID, 10(1), 2000, pp. 79-85
Authors:
DE la Vieja, A
Dohan, O
Levy, O
Carrasco, N
Citation: A. De La Vieja et al., Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology, PHYSIOL REV, 80(3), 2000, pp. 1083-1105
Authors:
Takats, KI
Szabolcs, I
Foldes, J
Foldes, I
Ferencz, A
Rimanoczy, E
Goth, M
Dohan, O
Kovacs, L
Szilagyi, G
Citation: Ki. Takats et al., The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses, EXP CL E D, 107(1), 1999, pp. 70-74